PSA
58
2
NEE
50
-5
GOOGL
40
-5
ADSK
70
2
CINF
53
2
HST
49
-9
PG
56
5
DHI
48
4
PEP
48
6
ES
34
3
HAS
33
3
MLM
57
6
CPB
30
6
KMI
67
-2
FSLR
54
7
APD
59
2
RSG
71
3
CL
58
2
EMN
60
4
URI
65
5
PSA
58
2
NEE
50
-5
GOOGL
40
-5
ADSK
70
2
CINF
53
2
HST
49
-9
PG
56
5
DHI
48
4
PEP
48
6
ES
34
3
HAS
33
3
MLM
57
6
CPB
30
6
KMI
67
-2
FSLR
54
7
APD
59
2
RSG
71
3
CL
58
2
EMN
60
4
URI
65
5
Financhill
Back

Arcutis Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
10.13
Seasonality Move:
101.78%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 55.7 Buy
Chaikin Money Flow: -485931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.53 - 10.27) Buy
Bollinger Bands (100): (8.99 - 10.49) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.97 Buy
20-day SMA: 9.64 Buy
50-day SMA: 9.59 Buy
200-day SMA: 9.5 Buy
8-day EMA: 10.03 Buy
20-day EMA: 9.79 Buy
50-day EMA: 9.65 Buy
200-day EMA: 9.16 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):